The National Academy of Sciences announced today the election of 120 members and 25 international members in recognition of ...

Proxygen announces two lead programs approaching clinical development, p300 and CDK12, addressing multiple cancer types Vienna, Austria, April 28, 2026 – Proxygen, a biotechnology company pioneering ...

A material built to tell left-handed light from right-handed light has long had a frustrating weakness. It mostly ignored ...

AcuraStem, a biotechnology company advancing treatments for amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and other neurodegenerative diseases, announced today that the ...

What's critical about this new facility is we currently have a situation in our healthcare and biotechnology programs where ...

Serif Biomedicines has emerged from stealth mode to continue developing “modified DNA,” a new class of therapeutics designed ...

Erasca is a high-risk, high-reward clinical-stage biotech focused on RAS/MAPK pathway-driven cancers. Click here to read this ...

Sweetness is one of the most important traits shaping fruit quality, market value, and consumer appeal, yet the molecular ...

DNA replication is one of life’s most precise and essential processes, ensuring genetic information is faithfully passed from cell to cell and generation to generation. This remarkable molecular ...

Urges Stockholders to Vote “FOR” Pacira’s Highly Qualified Nominees on the BLUE Proxy Card TodayStrongly Opposes the Election of Each of DOMA’s ...

No single diagnostic test was able to confirm all cases of spinal tuberculosis. AFB smear demonstrated the lowest detection ...

Crimson Chemicals Lands First U.S. Deal to Bring Hypercell Technologies' 1-Hour Pathogen Testing to Market FORT WORTH, TEXAS & ITHACA, N.Y. – April 27, ...